authors
- Eikelboom, John
- Hijazi, Z
- Verdecchia, P
- Oldgren, J
- Andersson, U
- Reboldi, MG
- Di Pasquale, G
- Mazzotta, G
- Angeli, F
- Ezekowitz, MD
- Connolly, Stuart
- Yusuf, Salim
- Wallentin, L
Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: experiences from the RELY trial
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- August 1, 2016
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Aged (MeSH)
- Anticoagulants (MeSH)
- Atrial Fibrillation (MeSH)
- Biomarkers (MeSH)
- Cause of Death (MeSH)
- Electrocardiography (MeSH)
- Female (MeSH)
- Follow-Up Studies (MeSH)
- Global Health (MeSH)
- Humans (MeSH)
- Hypertrophy, Left Ventricular (MeSH)
- Incidence (MeSH)
- Male (MeSH)
- Prognosis (MeSH)
- Retrospective Studies (MeSH)
- Risk Assessment (MeSH)
- Risk Factors (MeSH)
- Stroke (MeSH)
- Survival Rate (MeSH)
- Troponin I (MeSH)
- Troponin T (MeSH)
- Ventricular Function, Left (MeSH)